nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP1A2—Omeprazole—Barrett's esophagus	0.172	0.242	CbGbCtD
Nevirapine—CYP2C9—Omeprazole—Barrett's esophagus	0.155	0.218	CbGbCtD
Nevirapine—CYP3A4—Esomeprazole—Barrett's esophagus	0.153	0.215	CbGbCtD
Nevirapine—CYP2D6—Omeprazole—Barrett's esophagus	0.142	0.199	CbGbCtD
Nevirapine—CYP3A4—Omeprazole—Barrett's esophagus	0.09	0.127	CbGbCtD
Nevirapine—Oral disorder—Esomeprazole—Barrett's esophagus	0.0136	0.0484	CcSEcCtD
Nevirapine—Oral disorder—Omeprazole—Barrett's esophagus	0.0136	0.0484	CcSEcCtD
Nevirapine—Ulcerative stomatitis—Omeprazole—Barrett's esophagus	0.00743	0.0265	CcSEcCtD
Nevirapine—Ulcerative stomatitis—Esomeprazole—Barrett's esophagus	0.00743	0.0265	CcSEcCtD
Nevirapine—Foetor hepaticus—Omeprazole—Barrett's esophagus	0.00604	0.0215	CcSEcCtD
Nevirapine—Foetor hepaticus—Esomeprazole—Barrett's esophagus	0.00604	0.0215	CcSEcCtD
Nevirapine—Hepatic necrosis—Esomeprazole—Barrett's esophagus	0.0059	0.021	CcSEcCtD
Nevirapine—Hepatic necrosis—Omeprazole—Barrett's esophagus	0.0059	0.021	CcSEcCtD
Nevirapine—Liver disorder—Omeprazole—Barrett's esophagus	0.00503	0.0179	CcSEcCtD
Nevirapine—Liver disorder—Esomeprazole—Barrett's esophagus	0.00503	0.0179	CcSEcCtD
Nevirapine—Rash erythematous—Omeprazole—Barrett's esophagus	0.00448	0.016	CcSEcCtD
Nevirapine—Rash erythematous—Esomeprazole—Barrett's esophagus	0.00448	0.016	CcSEcCtD
Nevirapine—Necrosis—Omeprazole—Barrett's esophagus	0.00437	0.0156	CcSEcCtD
Nevirapine—Necrosis—Esomeprazole—Barrett's esophagus	0.00437	0.0156	CcSEcCtD
Nevirapine—Bone disorder—Omeprazole—Barrett's esophagus	0.0038	0.0135	CcSEcCtD
Nevirapine—Bone disorder—Esomeprazole—Barrett's esophagus	0.0038	0.0135	CcSEcCtD
Nevirapine—Hepatic enzyme increased—Esomeprazole—Barrett's esophagus	0.00363	0.0129	CcSEcCtD
Nevirapine—Hepatic enzyme increased—Omeprazole—Barrett's esophagus	0.00363	0.0129	CcSEcCtD
Nevirapine—Blood pressure increased—Esomeprazole—Barrett's esophagus	0.00343	0.0122	CcSEcCtD
Nevirapine—Hepatocellular injury—Esomeprazole—Barrett's esophagus	0.00343	0.0122	CcSEcCtD
Nevirapine—Blood pressure increased—Omeprazole—Barrett's esophagus	0.00343	0.0122	CcSEcCtD
Nevirapine—Hepatocellular injury—Omeprazole—Barrett's esophagus	0.00343	0.0122	CcSEcCtD
Nevirapine—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.00312	0.0111	CcSEcCtD
Nevirapine—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.00312	0.0111	CcSEcCtD
Nevirapine—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.0031	0.0111	CcSEcCtD
Nevirapine—Mouth ulceration—Omeprazole—Barrett's esophagus	0.0031	0.0111	CcSEcCtD
Nevirapine—Lymphadenopathy—Esomeprazole—Barrett's esophagus	0.00292	0.0104	CcSEcCtD
Nevirapine—Lymphadenopathy—Omeprazole—Barrett's esophagus	0.00292	0.0104	CcSEcCtD
Nevirapine—Hepatic failure—Esomeprazole—Barrett's esophagus	0.00277	0.00988	CcSEcCtD
Nevirapine—Hepatic failure—Omeprazole—Barrett's esophagus	0.00277	0.00988	CcSEcCtD
Nevirapine—Face oedema—Omeprazole—Barrett's esophagus	0.0024	0.00857	CcSEcCtD
Nevirapine—Face oedema—Esomeprazole—Barrett's esophagus	0.0024	0.00857	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.00224	0.00799	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00224	0.00799	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.00224	0.00799	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00224	0.00799	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.0022	0.00783	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.0022	0.00783	CcSEcCtD
Nevirapine—Pancreatitis—Omeprazole—Barrett's esophagus	0.00211	0.00752	CcSEcCtD
Nevirapine—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00211	0.00752	CcSEcCtD
Nevirapine—Neutropenia—Esomeprazole—Barrett's esophagus	0.00201	0.00717	CcSEcCtD
Nevirapine—Neutropenia—Omeprazole—Barrett's esophagus	0.00201	0.00717	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.0019	0.00678	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.0019	0.00678	CcSEcCtD
Nevirapine—Renal failure—Omeprazole—Barrett's esophagus	0.00189	0.00672	CcSEcCtD
Nevirapine—Renal failure—Esomeprazole—Barrett's esophagus	0.00189	0.00672	CcSEcCtD
Nevirapine—Jaundice—Omeprazole—Barrett's esophagus	0.00187	0.00667	CcSEcCtD
Nevirapine—Jaundice—Esomeprazole—Barrett's esophagus	0.00187	0.00667	CcSEcCtD
Nevirapine—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.00186	0.00665	CcSEcCtD
Nevirapine—Conjunctivitis—Omeprazole—Barrett's esophagus	0.00186	0.00665	CcSEcCtD
Nevirapine—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00181	0.00647	CcSEcCtD
Nevirapine—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00181	0.00647	CcSEcCtD
Nevirapine—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.00179	0.00638	CcSEcCtD
Nevirapine—Agranulocytosis—Omeprazole—Barrett's esophagus	0.00179	0.00638	CcSEcCtD
Nevirapine—Hepatitis—Omeprazole—Barrett's esophagus	0.00172	0.00614	CcSEcCtD
Nevirapine—Hepatitis—Esomeprazole—Barrett's esophagus	0.00172	0.00614	CcSEcCtD
Nevirapine—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00169	0.00603	CcSEcCtD
Nevirapine—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00169	0.00603	CcSEcCtD
Nevirapine—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00163	0.0058	CcSEcCtD
Nevirapine—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00163	0.0058	CcSEcCtD
Nevirapine—Immune system disorder—Omeprazole—Barrett's esophagus	0.00156	0.00555	CcSEcCtD
Nevirapine—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00156	0.00555	CcSEcCtD
Nevirapine—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.00139	0.00496	CcSEcCtD
Nevirapine—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.00139	0.00496	CcSEcCtD
Nevirapine—Anaemia—Omeprazole—Barrett's esophagus	0.00139	0.00494	CcSEcCtD
Nevirapine—Anaemia—Esomeprazole—Barrett's esophagus	0.00139	0.00494	CcSEcCtD
Nevirapine—Angioedema—Esomeprazole—Barrett's esophagus	0.00137	0.00488	CcSEcCtD
Nevirapine—Angioedema—Omeprazole—Barrett's esophagus	0.00137	0.00488	CcSEcCtD
Nevirapine—Malaise—Esomeprazole—Barrett's esophagus	0.00135	0.00482	CcSEcCtD
Nevirapine—Malaise—Omeprazole—Barrett's esophagus	0.00135	0.00482	CcSEcCtD
Nevirapine—Myalgia—Omeprazole—Barrett's esophagus	0.00128	0.00455	CcSEcCtD
Nevirapine—Arthralgia—Esomeprazole—Barrett's esophagus	0.00128	0.00455	CcSEcCtD
Nevirapine—Myalgia—Esomeprazole—Barrett's esophagus	0.00128	0.00455	CcSEcCtD
Nevirapine—Arthralgia—Omeprazole—Barrett's esophagus	0.00128	0.00455	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00127	0.00452	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00127	0.00452	CcSEcCtD
Nevirapine—Discomfort—Esomeprazole—Barrett's esophagus	0.00126	0.0045	CcSEcCtD
Nevirapine—Discomfort—Omeprazole—Barrett's esophagus	0.00126	0.0045	CcSEcCtD
Nevirapine—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00122	0.00436	CcSEcCtD
Nevirapine—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00122	0.00436	CcSEcCtD
Nevirapine—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.0012	0.00428	CcSEcCtD
Nevirapine—Nervous system disorder—Omeprazole—Barrett's esophagus	0.0012	0.00428	CcSEcCtD
Nevirapine—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.0012	0.00427	CcSEcCtD
Nevirapine—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.0012	0.00427	CcSEcCtD
Nevirapine—Skin disorder—Omeprazole—Barrett's esophagus	0.00119	0.00424	CcSEcCtD
Nevirapine—Skin disorder—Esomeprazole—Barrett's esophagus	0.00119	0.00424	CcSEcCtD
Nevirapine—Anorexia—Omeprazole—Barrett's esophagus	0.00117	0.00416	CcSEcCtD
Nevirapine—Anorexia—Esomeprazole—Barrett's esophagus	0.00117	0.00416	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00111	0.00397	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00111	0.00397	CcSEcCtD
Nevirapine—Paraesthesia—Esomeprazole—Barrett's esophagus	0.0011	0.00392	CcSEcCtD
Nevirapine—Paraesthesia—Omeprazole—Barrett's esophagus	0.0011	0.00392	CcSEcCtD
Nevirapine—Somnolence—Omeprazole—Barrett's esophagus	0.00109	0.00388	CcSEcCtD
Nevirapine—Somnolence—Esomeprazole—Barrett's esophagus	0.00109	0.00388	CcSEcCtD
Nevirapine—Decreased appetite—Omeprazole—Barrett's esophagus	0.00106	0.00379	CcSEcCtD
Nevirapine—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00106	0.00379	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00106	0.00377	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00106	0.00377	CcSEcCtD
Nevirapine—Fatigue—Omeprazole—Barrett's esophagus	0.00105	0.00376	CcSEcCtD
Nevirapine—Fatigue—Esomeprazole—Barrett's esophagus	0.00105	0.00376	CcSEcCtD
Nevirapine—Pain—Omeprazole—Barrett's esophagus	0.00105	0.00373	CcSEcCtD
Nevirapine—Pain—Esomeprazole—Barrett's esophagus	0.00105	0.00373	CcSEcCtD
Nevirapine—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.00101	0.00359	CcSEcCtD
Nevirapine—Feeling abnormal—Omeprazole—Barrett's esophagus	0.00101	0.00359	CcSEcCtD
Nevirapine—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.001	0.00357	CcSEcCtD
Nevirapine—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.001	0.00357	CcSEcCtD
Nevirapine—Urticaria—Omeprazole—Barrett's esophagus	0.000972	0.00347	CcSEcCtD
Nevirapine—Urticaria—Esomeprazole—Barrett's esophagus	0.000972	0.00347	CcSEcCtD
Nevirapine—Abdominal pain—Omeprazole—Barrett's esophagus	0.000967	0.00345	CcSEcCtD
Nevirapine—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000967	0.00345	CcSEcCtD
Nevirapine—Body temperature increased—Omeprazole—Barrett's esophagus	0.000967	0.00345	CcSEcCtD
Nevirapine—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000967	0.00345	CcSEcCtD
Nevirapine—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000901	0.00321	CcSEcCtD
Nevirapine—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000901	0.00321	CcSEcCtD
Nevirapine—Asthenia—Esomeprazole—Barrett's esophagus	0.000878	0.00313	CcSEcCtD
Nevirapine—Asthenia—Omeprazole—Barrett's esophagus	0.000878	0.00313	CcSEcCtD
Nevirapine—Pruritus—Omeprazole—Barrett's esophagus	0.000866	0.00309	CcSEcCtD
Nevirapine—Pruritus—Esomeprazole—Barrett's esophagus	0.000866	0.00309	CcSEcCtD
Nevirapine—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000837	0.00298	CcSEcCtD
Nevirapine—Diarrhoea—Omeprazole—Barrett's esophagus	0.000837	0.00298	CcSEcCtD
Nevirapine—Vomiting—Esomeprazole—Barrett's esophagus	0.000778	0.00277	CcSEcCtD
Nevirapine—Vomiting—Omeprazole—Barrett's esophagus	0.000778	0.00277	CcSEcCtD
Nevirapine—Rash—Omeprazole—Barrett's esophagus	0.000771	0.00275	CcSEcCtD
Nevirapine—Rash—Esomeprazole—Barrett's esophagus	0.000771	0.00275	CcSEcCtD
Nevirapine—Dermatitis—Omeprazole—Barrett's esophagus	0.000771	0.00275	CcSEcCtD
Nevirapine—Dermatitis—Esomeprazole—Barrett's esophagus	0.000771	0.00275	CcSEcCtD
Nevirapine—Headache—Esomeprazole—Barrett's esophagus	0.000767	0.00273	CcSEcCtD
Nevirapine—Headache—Omeprazole—Barrett's esophagus	0.000767	0.00273	CcSEcCtD
Nevirapine—Nausea—Esomeprazole—Barrett's esophagus	0.000727	0.00259	CcSEcCtD
Nevirapine—Nausea—Omeprazole—Barrett's esophagus	0.000727	0.00259	CcSEcCtD
Nevirapine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000356	0.0403	CbGpPWpGaD
Nevirapine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000356	0.0403	CbGpPWpGaD
Nevirapine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000281	0.0319	CbGpPWpGaD
Nevirapine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00028	0.0317	CbGpPWpGaD
Nevirapine—CYP2A6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000276	0.0313	CbGpPWpGaD
Nevirapine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000245	0.0278	CbGpPWpGaD
Nevirapine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000245	0.0278	CbGpPWpGaD
Nevirapine—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.000241	0.0273	CbGpPWpGaD
Nevirapine—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000237	0.0269	CbGpPWpGaD
Nevirapine—CYP2A6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000227	0.0257	CbGpPWpGaD
Nevirapine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000226	0.0256	CbGpPWpGaD
Nevirapine—CYP2B6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000223	0.0253	CbGpPWpGaD
Nevirapine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000221	0.025	CbGpPWpGaD
Nevirapine—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000218	0.0247	CbGpPWpGaD
Nevirapine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000209	0.0237	CbGpPWpGaD
Nevirapine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000209	0.0237	CbGpPWpGaD
Nevirapine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—Barrett's esophagus	0.000208	0.0236	CbGpPWpGaD
Nevirapine—CYP1A2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000203	0.023	CbGpPWpGaD
Nevirapine—CYP2B6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000183	0.0208	CbGpPWpGaD
Nevirapine—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000179	0.0203	CbGpPWpGaD
Nevirapine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000162	0.0183	CbGpPWpGaD
Nevirapine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000162	0.0183	CbGpPWpGaD
Nevirapine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000157	0.0178	CbGpPWpGaD
Nevirapine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000156	0.0176	CbGpPWpGaD
Nevirapine—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000155	0.0176	CbGpPWpGaD
Nevirapine—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000153	0.0174	CbGpPWpGaD
Nevirapine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000133	0.0151	CbGpPWpGaD
Nevirapine—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000131	0.0149	CbGpPWpGaD
Nevirapine—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000127	0.0144	CbGpPWpGaD
Nevirapine—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000126	0.0143	CbGpPWpGaD
Nevirapine—CYP2A6—Biological oxidations—CYP26A1—Barrett's esophagus	0.00012	0.0137	CbGpPWpGaD
Nevirapine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000117	0.0133	CbGpPWpGaD
Nevirapine—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000112	0.0127	CbGpPWpGaD
Nevirapine—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000108	0.0122	CbGpPWpGaD
Nevirapine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000103	0.0116	CbGpPWpGaD
Nevirapine—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000101	0.0115	CbGpPWpGaD
Nevirapine—CYP2B6—Biological oxidations—CYP26A1—Barrett's esophagus	9.72e-05	0.011	CbGpPWpGaD
Nevirapine—CYP2B6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	9.59e-05	0.0109	CbGpPWpGaD
Nevirapine—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	9.5e-05	0.0108	CbGpPWpGaD
Nevirapine—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	9.37e-05	0.0106	CbGpPWpGaD
Nevirapine—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	8.31e-05	0.00943	CbGpPWpGaD
Nevirapine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	8.06e-05	0.00914	CbGpPWpGaD
Nevirapine—CYP2A6—Fluoropyrimidine Activity—TP53—Barrett's esophagus	6.95e-05	0.00789	CbGpPWpGaD
Nevirapine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	6.89e-05	0.00781	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	6.76e-05	0.00766	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	6.7e-05	0.0076	CbGpPWpGaD
Nevirapine—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	6.66e-05	0.00756	CbGpPWpGaD
Nevirapine—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	6.6e-05	0.00749	CbGpPWpGaD
Nevirapine—CYP2A6—NRF2 pathway—HGF—Barrett's esophagus	6.31e-05	0.00715	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	5.72e-05	0.00649	CbGpPWpGaD
Nevirapine—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	5.64e-05	0.0064	CbGpPWpGaD
Nevirapine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	5.32e-05	0.00603	CbGpPWpGaD
Nevirapine—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	4.66e-05	0.00528	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	4.42e-05	0.00501	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	4.38e-05	0.00497	CbGpPWpGaD
Nevirapine—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	4.36e-05	0.00494	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	4.25e-05	0.00483	CbGpPWpGaD
Nevirapine—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	3.98e-05	0.00451	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	3.39e-05	0.00385	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	2.9e-05	0.00329	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGES—Barrett's esophagus	2.72e-05	0.00308	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGES—Barrett's esophagus	2.19e-05	0.00249	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGES—Barrett's esophagus	2.14e-05	0.00243	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYP26A1—Barrett's esophagus	2.06e-05	0.00234	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP26A1—Barrett's esophagus	1.66e-05	0.00189	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	1.62e-05	0.00184	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGES—Barrett's esophagus	1.52e-05	0.00173	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGES—Barrett's esophagus	1.51e-05	0.00171	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—SLC9A1—Barrett's esophagus	1.49e-05	0.00168	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGES—Barrett's esophagus	1.29e-05	0.00146	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—SLC9A1—Barrett's esophagus	1.2e-05	0.00136	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	1.17e-05	0.00133	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	1.16e-05	0.00131	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	1.15e-05	0.0013	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGES—Barrett's esophagus	9.97e-06	0.00113	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	9.79e-06	0.00111	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	8.46e-06	0.00096	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	8.33e-06	0.000945	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	8.26e-06	0.000936	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	7.55e-06	0.000857	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	7.23e-06	0.00082	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	7.05e-06	0.0008	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PPARG—Barrett's esophagus	6.78e-06	0.000769	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	6.66e-06	0.000755	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	5.69e-06	0.000645	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARG—Barrett's esophagus	5.47e-06	0.00062	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	5.44e-06	0.000618	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARG—Barrett's esophagus	5.35e-06	0.000606	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS2—Barrett's esophagus	5.33e-06	0.000605	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS2—Barrett's esophagus	4.3e-06	0.000488	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	4.21e-06	0.000477	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARG—Barrett's esophagus	3.8e-06	0.000431	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARG—Barrett's esophagus	3.77e-06	0.000427	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARG—Barrett's esophagus	3.22e-06	0.000365	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	2.99e-06	0.000339	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	2.96e-06	0.000336	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	2.53e-06	0.000287	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARG—Barrett's esophagus	2.49e-06	0.000282	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	1.96e-06	0.000222	CbGpPWpGaD
